Evidence map›Paper›PMID 41749173›Full record

ArticleBMC infectious diseases2026

C-reactive protein, white blood cell counts and sequential interpretation of PfHRP2/pLDH for antibiotic stewardship in children under 5 years of age.

Francois Kiemde, Marc Christian Tahita, Toussaint Rouamba, Massa Dit Achille Bonko, Palpouguini Lompo, Sibidou Yougbare, Petra F Mens, Halidou Tinto, Henk D F H Schallig

Abstract read
In one paragraph

Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Francois KiemdeClinical Research Unit of Nanoro, Institut de Recherche en Sciences de la Santé, 11 BP 218, Ouagadougou CMS 11, Nanoro, Burkina Faso. kiemdefrancois@yahoo.fr.
Marc Christian TahitaClinical Research Unit of Nanoro, Institut de Recherche en Sciences de la Santé, 11 BP 218, Ouagadougou CMS 11, Nanoro, Burkina Faso.
Toussaint RouambaClinical Research Unit of Nanoro, Institut de Recherche en Sciences de la Santé, 11 BP 218, Ouagadougou CMS 11, Nanoro, Burkina Faso.
Massa Dit Achille BonkoClinical Research Unit of Nanoro, Institut de Recherche en Sciences de la Santé, 11 BP 218, Ouagadougou CMS 11, Nanoro, Burkina Faso.
Palpouguini LompoClinical Research Unit of Nanoro, Institut de Recherche en Sciences de la Santé, 11 BP 218, Ouagadougou CMS 11, Nanoro, Burkina Faso.
Sibidou YougbareClinical Research Unit of Nanoro, Institut de Recherche en Sciences de la Santé, 11 BP 218, Ouagadougou CMS 11, Nanoro, Burkina Faso.
Petra F MensLaboratory for Experimental Parasitology, Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Halidou TintoClinical Research Unit of Nanoro, Institut de Recherche en Sciences de la Santé, 11 BP 218, Ouagadougou CMS 11, Nanoro, Burkina Faso.
Henk D F H SchalligLaboratory for Experimental Parasitology, Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, Amsterdam, The Netherlands.

Funding

The Netherlands Organization for Health Research and Development 205300005; RAPDIF
6 · The paper itself

Abstract

backgroundIn sub-Saharan Africa, the management of non-malaria acute febrile illnesses remains challenging in peripheral health centers without laboratory facilities. This study retrospectively assessed diagnostic approaches constructed through the integration of biological data and clinical information from established database to assess their potential impact on antibiotics prescribing practices within an antimicrobial stewardship framework in malaria endemic areas.

methodsData from 396 febrile children (axillary temperature ≥37.5 °C) under 5 years of age, collected between April and December 2016 were retrospectively analyzed. Diagnostic approaches integrating malaria RDT results (sequential interpretation of PfHRP2/pLDH and PfHRP2-only), C-reactive protein (CRP), white blood cell (WBC) counts, microbiological findings (blood, stool, and urine) and recorded antibiotic prescription were assessed. Association between malaria diagnostic results and clinical/biological data were assessed using logistical regression, adjusted for age, sex, axillary temperature, CRP value, WBC count and microbiological findings. Malaria sequential diagnostic results with malaria RDT-PfHRP2/pLDH were interpreted and reported as either (i) positive when the T2-pLDH line appear, regardless of the results of T1-HRP2 line, (ii) negative when both T1-HRP2 and T2-pLDH lines do not appear, or (iii) undetermined when the T1-HRP2 line only appears.

resultsUsing malaria sequential diagnostic approach, logistic regression of malaria-negative or undetermined results showed a negative correlation with axillary temperature > 38.5 °C (aOR 0.37; 95% CI 0.24–0.58; p < 0.001) and CRP value ≥10 mg/L (aOR 0.13; 95% CI 0.06–0.26; p < 0.001), but a positive correlation with WBC counts > 14 × 103/µL (aOR 2.57; 95% CI 1.39–4.79, p = 0.003), compared with malaria-positive results. In children with malaria-negative or undetermined sequential results, negative malaria tests showed a positive correlation with CRP ≥10 mg/L (aOR 3.46; 95% CI 1.51–8.82; p = 0.005), but a negative correlation with WBC counts > 14 × 103/µL (aOR 0.38; 95% CI 0.15–0.93; p = 0.037), compared with malaria-undetermined results. The optimal diagnostic approach combining PfHRP2-only results with CRP values and WBC counts predicted the need for antibiotic prescriptions in 18.7% (74/396), potentially identifying 9/23 sepsis cases. When using sequential malaria diagnostic approach combined with CRP values and WBC counts, antibiotic need was predicted in 25.5% (101/396), potentially identifying 18/23 sepsis cases.

conclusionIntegrating sequential malaria diagnostics with CRP, WBC counts, and clinical information improves differentiation of febrile illnesses and supports more targeted antibiotic use in malaria-endemic settings. CLINICAL TRIAL: Not applicable.

Indexed as

Antigens, ProtozoanAntimicrobial StewardshipC-Reactive ProteinMalaria, FalciparumProtozoan ProteinsAnti-Bacterial AgentsChild, PreschoolFemaleFeverHumansInfantLeukocyte CountMalePlasmodium falciparumRetrospective StudiesAnti-Bacterial AgentsAntigens, ProtozoanC-Reactive ProteinHRP-2 antigen, Plasmodium falciparumProtozoan ProteinsBacterial infectionC-reactive proteinFeverMalariaSequential diagnosticWhite blood cell counts

Identifiers

PMID41749173
PMCPMC13049993

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.